R384-203-3. Criteria for Application to Access Prescription Drug Database  


Latest version.
  •   (1) The study must fit within the responsibilities of the Department for health and welfare.

      (2) De-identified prescriber, patient and pharmacy data will meet the research needs.

      (3) The research facility designee must provide:

      (a) written assurances that the studies are not conducted for and will not be used for profit or commercial gain;

      (b) written assurances that the designee shall protect the information as a business associate of the Department of Health; and

      (c) documentation of an Institutional Review Board approval.